Quiz 4 Flashcards
Heparin
Action
Use
Administration
Antidote
Bind with antithrombin III (inhibit clot formation, stops coagulation cascade)
Prevent venous thrombosis
SubQ: prevention
IV: treatment
Protamine sulfate
Adverse effects of heparin
Nosebleeds, blood urine and stool, bloody gums
Heparin-induced thrombocytopenia (low platelets caused by heparin)
Antidote of warfarin
Vitamin K
Direct Factor Xa
Antagonist
Prototype
Action
Use
Rivaroxaban (Xarelto)
Inhibits platelet activation
Prevention of VTE and stroke
Adverse reactions of alteplase
Antidote
Hemorrhage
Aminocaproic acid
3 factors the predispose pts to thrombosis
Stasis: blood slow = > cot
Vascular damage
Hypercoagulability: > chance of coagulation
Arterial clot formation vs venous clot formation
Arterial: damaged vessels
Venous: caused by circulatory stasis
Heparin lab (what is it)
Therapeutic
apTT: how long it takes for a clot to form (activated thromboplastin time)
45-70 sec
Enoxaparin (lovenox)
What is it?
Administration
Labs
Low-molecular-weight heparin (having a low molecular weight)
SubQ
Frequent lab monitoring not required
Contraindication of enoxaparin
renal impairment
Side effects of enoxaparin
lower risk of bleeding
Vitamin K antagonist
Prototype
Action
Use
Warfarin (Coumadin)
Inhibits hepatic synthesis of Vitamin K
Prevent thromboembolic events
Labs for warfarin
INR (international normalized ratio). Time it takes to clot
Therapeutic range: 2-3
(calculated from PT (prothrombin time))
Antiplatelet
Prototype
Action
Use
OTC
Clopidogrel (plavix)
Action: irreversibly suppresses platelets (platelet lifespan is 7-10 days)
Prevents new clots or prevent them from getting bigger
Aspirin
Thrombolytic
Prototype
Action
Use
Alteplase (Activase)
Bind to fibrin promoting conversion of plasminogen to plasmin (plasmin digests fibrin)
Disintegrates clots
When do we give alteplase
Severe cases where leg isn’t being perfused
Ischemic stroke
Erythropoiesis-stimulating agents
Prototype
MOA
Use
Epoetin alfa (procrit)
Mimics hormone erythropoietin. Only give if benefits > risk
Anemia secondary to chemotherapy or kidney disease
Granulocyte colony stimulating factor
Prototype
MOA
Use
Administration
Filgrastim (neupogen)
Tell bone marrow to make more neutrophils
Neutropenia secondary to marrow transplant or chemo
SubQ or IV
Adverse effects of filgrastim
Flu-like symptoms
Arthralgia (joint stiffness)
Splenomegaly
Interferons
Prototype
MOA
Use
Administration
Interferon alfa 2B
Antiviral, destroys viruses
Antineoplastic, boost immune response
SubQ or IM (3 times a week)
What are interferons
Functions
Proteins naturally occurring in the body (alpha, beta, gamma)
Slow growth of cancer cells, stimulate certain WBCs to fight cancer, antiviral effects
Black box warning on Epoetin alfa
Hemoglobin must be < 10 g/dl
Avoid if hemoglobin > 12g/dl = > blood clots
Epoetin alfa
Administration
SubQ, IV
Nursing interventions of filgrastim
Palpating abdominal in case of splenomegaly